Doctor Ayman Hammoudeh

Doctor Ayman Hammoudeh

Istishari Hospital, Amman (Jordan)

Dr. Ayman Hammoudeh obtained his MD degree from the Jordan University School of Medicine, Amman, Jordan in 1986 and in 1989, he joined the Internal Medicine Residency and then cardiology fellowship Program at St. Michael’s Medical Center (Seton Hall University School of Graduate Medical Education), New Jersey, USA and was awarded the American Board of Cardiovascular Disease in 1996 and the Interventional Cardiology Certificate from Seton Hall University in 1997. He is currently an interventional cardiologist at the Cardiovascular Consulting Group/Istishari Hospital, Amman. Dr. Hammoudeh is a fellow of the American College of Cardiology since 1998. He is a member of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and is the PI of 8 Jordanian CV studies including JoHARTS, MINTOR, CAPRIS, GLORY, JoPCR1, and Statin Epic. His work appeared in >70 articles in the American Heart Journal, Clinical Research, New England Journal of Medicine, Cardiology In Review.

Presentations

Utilization of Guidelines-recommended secondary cardiovascular preventive medications in a decade or more survivors after coronary revascularization in the Middle East; analysis form the DECADE PLUS S

Event: ESC Congress 2020

Topic: Secondary Prevention

Session: Risk Factors and Prevention ePosters

Access

Surviving a decade or more after coronary revascularization in the Middle East: cardiovascular events and the need for further arterial revascularization

Event: EuroPrevent 2019

Topic: Cardiovascular Disease in Special Populations, Other

Session: Cardiovascular Disease in Special Populations

Access

Utilization of Guidelines-recommended secondary cardiovascular preventive medications in a decade or more survivors after coronary revascularization in the Middle East; analysis form the DECADE PLUS S

Event: ESC Asia with APSC & AFC 2020

Topic: Secondary Prevention

Session: Abstract Programme

Access

Doctor Ayman Hammoudeh

Biography

Contributor content

Utilization of Guidelines-recommended secondary cardiovascular preventive medications in a decade or more survivors after coronary revascularization in the Middle East; analysis form the DECADE PLUS S

Surviving a decade or more after coronary revascularization in the Middle East: cardiovascular events and the need for further arterial revascularization

Utilization of Guidelines-recommended secondary cardiovascular preventive medications in a decade or more survivors after coronary revascularization in the Middle East; analysis form the DECADE PLUS S

ESC 365 is supported by